|
|
|
Volumn 20, Issue 5 Suppl 4, 2006, Pages 22-28
|
|
Risk assessment and guidelines for first-cycle colony-stimulating factor use in the management of chemotherapy-induced neutropenia.
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;
CHEMICALLY INDUCED DISORDER;
HUMAN;
NEOPLASM;
NEUTROPENIA;
PRACTICE GUIDELINE;
REVIEW;
RISK ASSESSMENT;
RISK FACTOR;
ANTINEOPLASTIC AGENTS;
GRANULOCYTE COLONY STIMULATING FACTOR, RECOMBINANT;
HUMANS;
NEOPLASMS;
NEUTROPENIA;
RISK ASSESSMENT;
RISK FACTORS;
|
|
EID: 33749160501
PISSN: 08909091
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (19)
|
|
References (27)
|
